164 results
Page 3 of 9
6-K
EX-99.1
1e4k6p i4
14 Oct 21
51-102F3 Material Change Report
4:00pm
6-K
EX-99.1
b1nowd62nlgnmge
13 Oct 21
RepliCel Life Sciences Appoints One of Japan’s Foremost Regenerative Medicine Industry Business Leaders as Strategic Advisor
12:00am
6-K
EX-99.1
fyn9a7ie q8v6m
12 Oct 21
RepliCel and University of Victoria Collaboration Leads to Bioengineering Innovations, Funding, and Patents
1:06pm
6-K
EX-99.2
zlo6rd7sedky nw3
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.1
x43k5seek
18 Aug 21
RepliCel Applies for Manufacturing Approval for its Collagen and Tissue Regeneration Cell Therapies
12:38pm
6-K
EX-99.3
yr5 ddmtojgmf
18 Aug 21
RepliCel Life Sciences Announces Closing of Debt Settlement
12:34pm
6-K
EX-99.1
na0gr1orq74jh
18 Aug 21
RepliCel Life Sciences Announces Closing of Debt Settlement
12:34pm
6-K
EX-99.2
7j59qmb
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.4
9quuwaxfcw2b
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.3
0od1afbpkfo
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.1
jy60sr4vhq5ygues2066
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.5
f1hy6u8
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.6
1yhwimx
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.7
smhrr5lu6
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.3
hwc566763f7u
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.2
iio4l9 efbn8u1m
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.3
q8ndmz mcd
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.1
fm484kahmhribzr8yr
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.1
pkis4ml9k24qya kz
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.2
p4cyigkud3jd0 ckp22
13 Aug 21
51-102F3 Material Change Report
12:00am